Furthermore, the authors verified this result with clinical data showing that low expression of miR‐139‐5p and high expression of SLC7A11 are associated with a poor prognosis, indicating that miR‐139‐5p may represent a new biomarker of pancreatic cancer.27 Here, SLC7A11 is linked to familial pancreatic carcinoma.